Petros Pharmaceuticals, Inc.
PTPI
$0.0919
-$0.0106-10.34%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -47.79% | -32.68% | -16.92% | -25.78% | 143.34% |
| Total Receivables | 9.69% | -9.22% | -12.09% | -25.17% | 15.46% |
| Inventory | 7.28% | 3.93% | -1.91% | 11.68% | 14.73% |
| Prepaid Expenses | -35.65% | -42.74% | -9.92% | 417.77% | -19.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 12.26% | 23.25% | 25.93% | 8.55% | 5.04% |
| Total Current Assets | -23.28% | -21.92% | -12.20% | -16.55% | 85.79% |
|
|
|||||
| Total Current Assets | -23.28% | -21.92% | -12.20% | -16.55% | 85.79% |
| Net Property, Plant & Equipment | -19.09% | -18.16% | -14.97% | -12.72% | -10.99% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -9.49% | -8.66% | -7.97% | -8.19% | -7.78% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -13.60% | -11.81% | -5.79% | -5.40% | -5.05% |
| Total Assets | -17.78% | -16.97% | -10.31% | -13.15% | 35.46% |
|
|
|||||
| Total Accounts Payable | 102.38% | -62.99% | 24.75% | 26.43% | -24.03% |
| Total Accrued Expenses | 52.72% | -24.77% | -19.61% | 35.45% | 8.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.09% | 24.67% | 21.23% | -0.51% | 1.00% |
| Total Finance Division Other Current Liabilities | 6.74% | 7.35% | 8.49% | 48.84% | 12.77% |
| Total Other Current Liabilities | 6.74% | 7.35% | 8.49% | 48.84% | 12.77% |
| Total Current Liabilities | 25.92% | -11.08% | 4.17% | 33.27% | 1.47% |
|
|
|||||
| Total Current Liabilities | 25.92% | -11.08% | 4.17% | 33.27% | 1.47% |
| Long-Term Debt | -13.59% | -11.81% | -5.79% | -5.40% | -5.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.84% | -12.36% | -10.68% | -9.05% | -17.40% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -88.88% | -48.85% | -78.32% | -- |
| Total Liabilities | 9.97% | -18.53% | -7.96% | -33.09% | 101.85% |
|
|
|||||
| Common Stock & APIC | -2.49% | -0.95% | -0.11% | 4.54% | -1.36% |
| Retained Earnings | -2.18% | -0.66% | -2.19% | 0.32% | -4.81% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -61.39% | -17.54% | -18.92% | 74.12% | -46.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -99.87% | 23.02% | 121.76% | 228.51% | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -99.87% | 23.02% | 121.76% | 228.51% | -- |
|
|
|||||
| Total Common Equity | -61.39% | -17.54% | -18.92% | 74.12% | -46.44% |
| Total Preferred Equity | -99.87% | 23.02% | 121.76% | 228.51% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -66.07% | -14.10% | -14.31% | 76.84% | -45.48% |
|
|
|||||
